Home

Daniel Emmett Clark

CIK 1874449 · Secretary and General Counsel · last filed 2023-05-04

Daniel Emmett Clark is a Secretary and General Counsel who has filed 13 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for WGSWW, was dated May 4, 2023. Across all open-market trades the lifetime net is −$19.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $63 across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$63

Companies

2

Total Filings

13

Lifetime Open-Market Net

-$19.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WGSWW 313,552 $0.00 $63 -$1.6K 1 2023-05-04
GeneDx Holdings Corp. (SMFRW) Delisted Secretary and General Counsel 313,487 $0.02 $7.5K -$18.3K 12 2022-07-27

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-05-04 WGSWW Mixed +2,798 -$1.6K EDGAR
2022-07-27 GeneDx Holdings Corp. (SMFRW) Delisted Mixed +2,660 -$1.9K EDGAR
2022-05-02 GeneDx Holdings Corp. (SMFRW) Delisted Sell (S) −1,212 -$2.6K EDGAR
2022-04-27 GeneDx Holdings Corp. (SMFRW) Delisted Exer (M) +3,940 $0 EDGAR
2022-04-06 GeneDx Holdings Corp. (SMFRW) Delisted Grant (A) — $0 EDGAR
2022-02-02 GeneDx Holdings Corp. (SMFRW) Delisted Sell (S) −1,512 -$4.3K EDGAR
2022-01-27 GeneDx Holdings Corp. (SMFRW) Delisted Exer (M) +3,940 $0 EDGAR
2022-01-19 GeneDx Holdings Corp. (SMFRW) Delisted Exer (M) +275,000 $42.0K EDGAR
2021-12-13 GeneDx Holdings Corp. (SMFRW) Delisted Grant (A) — $0 EDGAR
2021-12-03 GeneDx Holdings Corp. (SMFRW) Delisted Mixed +3,707 $23.5K EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.